Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-008376
Filing Date
2022-03-01
Accepted
2022-03-01 18:39:05
Documents
2
Period of Report
2022-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2949
2 EX-24 DOCUMENT attachment1.htm EX-24 3960
  Complete submission text file 0000899243-22-008376.txt   8309
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 89BIO, INC. 142 SANSOME STREET, SECOND FLOOR SAN FRANCISCO CA 94104
Business Address
Atkinson Edward Morrow III (Reporting) CIK: 0001914164 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39122 | Film No.: 22700434